Can 3110 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Can 3110. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Can 3110 Today - Breaking & Trending Today

FDA Grants Fast Track Designation to CAN-3110 for Recurrent High-Grade Glioma

Published: February 13, 2024

CAN-3110, an HSV-1 oncolytic viral immunotherapy candidate, has received FDA fast track designation for adult patients with recurrent high-grade glioma.

Source: onclive.com

Related Topics:

United StatesAntonio ChioccaHarvard Medical SchoolDepartment Of Neurosurgery At BrighamPeter TakCandel TherapeuticsCan 3110Adult Patients With Recurrent High Grade GliomaPaul Peter TakBrigham And Womens Hospital